BUSINESS● LOWSep 20 · Sep 20, 2026, 4:00 AM
Novo investors call for dealmaking and new drugs
Financial Times · global
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowBusiness climate in Cameroon: Célestin Tawamba maintains pressure on Joseph Dion NguteJeune AfriqueBUSINESS5m agoMicrosoft offers buyouts to 60,000 workers as it invests more in AICBS News